Inflexion sells majority stake in Celnor to Goldman Sachs Alternatives

Oct 23 (Reuters) - Private equity firm Inflexion said on Friday it would sell a majority stake in British testing and safety compliance company Celnor Group to Goldman Sachs Alternatives.

• Terms of the deal were not disclosed, but the deal values Celnor at €1 billion ($1.12 billion), according to a person familiar with the situation

• Inflexion said it will keep a minority stake in Celnor, a company it helped set up in 2023

• Celnor has pursued an acquisition-led strategy, gaining momentum in the UK and expanding in the US and Europe, the European private equity firm said

• The company has previously acquired US-based firms such as John Turner Consulting and French firms Tera Environnement and Toxilabo

• Celnor, whose services span asbestos testing to food safety research, said in a separate statement that Goldman Sachs will support its expansion in the US and Continental Europe and bolster its acquisition capabilities

• Goldman Sachs declined to comment when contacted by Reuters

($1 = 0.8928 euros)

(Reporting by Simone Lobo in Bengaluru; Editing by Vijay Kishore)